NFKB1 and colitis: In different experimental models of colitis, PCs have exhibited anti-inflammatory actions, usually through interference with NF-κB, resulting in the downregulation of several inflammatory mediators, including the suppression of downstream pro-inflammatory cytokines [46,47].